Cargando…

Mitochondrial Oxidative Metabolism: An Emerging Therapeutic Target to Improve CKD Outcomes

Chronic kidney disease (CKD) predisposes one toward end-stage renal disease (ESRD) and its associated morbidity and mortality. Significant metabolic perturbations in conjunction with alterations in redox status during CKD may induce increased production of reactive oxygen species (ROS), including su...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mapuskar, Kranti A., Vasquez-Martinez, Gabriela, Mayoral-Andrade, Gabriel, Tomanek-Chalkley, Ann, Zepeda-Orozco, Diana, Allen, Bryan G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10295466/ https://www.ncbi.nlm.nih.gov/pubmed/37371668 http://dx.doi.org/10.3390/biomedicines11061573

Ejemplares similares

Tubular Mitochondrial Pyruvate Carrier Disruption Elicits Redox Adaptations that Protect from Acute Kidney Injury
por: Rauckhorst, Adam J., et al.
Publicado: (2023)

Redox Regulation of Nrf2 in Cisplatin-Induced Kidney Injury
por: Mapuskar, Kranti A., et al.
Publicado: (2023)

Persistent increase in mitochondrial superoxide mediates cisplatin-induced chronic kidney disease
por: Mapuskar, Kranti A., et al.
Publicado: (2018)

Mitochondrial Superoxide Dismutase in Cisplatin-Induced Kidney Injury
por: Mapuskar, Kranti A., et al.
Publicado: (2021)

Allopurinol Lowers Serum Urate but Does Not Reduce Oxidative Stress in CKD
por: Sun, Mingyao, et al.
Publicado: (2022)

Mitochondrial-Targeted Decyl-Triphenylphosphonium Enhances 2-Deoxy-D-Glucose Mediated Oxidative Stress and Clonogenic Killing of Multiple Myeloma Cells
por: Schibler, Jeanine, et al.
Publicado: (2016)

Succinate Accumulation Links Mitochondrial MnSOD Depletion to Aberrant Nuclear DNA Methylation and Altered Cell Fate
por: Cramer-Morales, Kimberly L., et al.
Publicado: (2020)

Evaluating the iron chelator function of sirtinol in non-small cell lung cancer
por: Petronek, Michael S., et al.
Publicado: (2023)

Human Skin Keratinocytes Can Be Reprogrammed to Express Neuronal Genes and Proteins After a Single Treatment with Decitabine
por: Bickenbach, Jackie R., et al.
Publicado: (2013)

Uric Acid Lowering and Biomarkers of Kidney Damage in CKD Stage 3: A Post Hoc Analysis of a Randomized Clinical Trial
por: Perrenoud, Loni, et al.
Publicado: (2020)

The emerging role of magnesium in CKD
por: Sakaguchi, Yusuke
Publicado: (2022)

Transient expression of OCT4 is sufficient to allow human keratinocytes to change their differentiation pathway
por: Racila, Doina, et al.
Publicado: (2010)

Emerging Role of Clinical Genetics in CKD
por: Devarajan, Prasad, et al.
Publicado: (2022)

Hyperkalemia in CKD: an overview of available therapeutic strategies
por: Costa, Davide, et al.
Publicado: (2023)

Redox active metals and H(2)O(2) mediate the increased efficacy of pharmacological ascorbate in combination with gemcitabine or radiation in pre-clinical sarcoma models()
por: Schoenfeld, Joshua D., et al.
Publicado: (2017)

Utilization of Pharmacological Ascorbate to Enhance Hydrogen Peroxide-Mediated Radiosensitivity in Cancer Therapy
por: Mehdi, Zain, et al.
Publicado: (2021)

A letter to the editor on “World Health Organization declares global emergency: A review of the 2019 novel Coronavirus (COVID-19)”
por: Pérez-Campos Mayoral, Laura, et al.
Publicado: (2020)

Ketogenic diets as an adjuvant cancer therapy: History and potential mechanism
por: Allen, Bryan G., et al.
Publicado: (2014)

The Emerging Role of Nutritional Vitamin D in Secondary Hyperparathyroidism in CKD
por: Lu, Chien-Lin, et al.
Publicado: (2018)

The emerging role of iron in heart failure and vascular calcification in CKD
por: Ciceri, Paola, et al.
Publicado: (2020)

Intermedin Alleviates Vascular Calcification in CKD through Sirtuin 3-Mediated Inhibition of Mitochondrial Oxidative Stress
por: Liu, Shi-Meng, et al.
Publicado: (2022)

Masked CKD in hyperthyroidism and reversible CKD status in hypothyroidism
por: Uchiyama-Matsuoka, Natsumi, et al.
Publicado: (2022)

Dialysis disequilibrium syndrome
por: Zepeda-Orozco, Diana, et al.
Publicado: (2012)

Benchmarking CKD: incidence of CKD in a European country with low prevalence of CKD and kidney replacement therapy
por: Ortiz, Alberto
Publicado: (2022)

Redox nanomedicine ameliorates chronic kidney disease (CKD) by mitochondrial reconditioning in mice
por: Adhikari, Aniruddha, et al.
Publicado: (2021)

Constipation in CKD
por: Sumida, Keiichi, et al.
Publicado: (2019)

The Road from AKI to CKD: Molecular Mechanisms and Therapeutic Targets of Ferroptosis
por: Guo, Runzhi, et al.
Publicado: (2023)

CKD Awareness in the General Population: Performance of CKD-Specific Questions
por: Tuot, Delphine S., et al.
Publicado: (2019)

Autosomal Dominant Tubulointerstitial Kidney Disease: An Emerging Cause of Genetic CKD
por: Econimo, Laura, et al.
Publicado: (2022)

Molecules and Prostaglandins Related to Embryo Tolerance
por: Mayoral Andrade, Gabriel, et al.
Publicado: (2020)

CKD Prevalence in the Military Health System: Coded Versus Uncoded CKD
por: Norton, Jenna M., et al.
Publicado: (2021)

High-Density Lipoprotein Lipidomics and Mortality in CKD
por: Lidgard, Benjamin, et al.
Publicado: (2023)

Raising awareness on the therapeutic role of cholecalciferol in CKD: a multidisciplinary-based opinion
por: Giannini, Sandro, et al.
Publicado: (2017)

Uremic Toxins and Protein-Bound Therapeutics in AKI and CKD: Up-to-Date Evidence
por: Chen, Jia-Huang, et al.
Publicado: (2021)

Calcimimetics and outcomes in CKD
por: Drüeke, Tilman B
Publicado: (2013)

CKD in disadvantaged populations
por: Garcia-Garcia, Guillermo, et al.
Publicado: (2015)

Editorial: Biomarkers in CKD
por: Araujo, Magali, et al.
Publicado: (2017)

Frailty in CKD and Transplantation
por: Lorenz, Elizabeth C., et al.
Publicado: (2021)

Phosphate, Microbiota and CKD
por: Favero, Chiara, et al.
Publicado: (2021)

The Role of Inflammation in CKD
por: Kadatane, Saurav Prashant, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_t5hms290plj4ni67urhnlotjav